vTv Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | -225.0% | – | |
| – | +4.5% | -4.3% | +4.5% | -4.3% | +0.0% | -59.1% | -66.7% | -33.3% | +0.0% | -50.0% | +0.0% | – | |
| – | -6.9% | -45.4% | +290.5% | -0.7% | -3.3% | -1.5% | +14.4% | +8.3% | +1.8% | +35.4% | +124.4% | – | |
| – | – | -250.0% | – | – | – | +7,028.6% | +184.2% | -136.2% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -200.0% | – | – | – | |
| – | -159.6% | – | -100.0% | – | -100.0% | – | – | – | -100.4% | – | – | – | |
| – | – | +3,443.8% | -115.7% | – | – | – | – | – | -113.2% | – | -225.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | -225.0% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.